Clinical trial
Cancer Risk in Carriers of the Gene for Xeroderma Pigmentosum
NCT00046189 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00046189 |
|---|---|
| Title | Cancer Risk in Carriers of the Gene for Xeroderma Pigmentosum |
| Official title | Cancer Risk in Xeroderma Pigmentosum Heterozygotes |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Xeroderma Pigmentosum, Basal Cell Carcinoma, Squamous Cell Carcinoma, Melanoma, Skin Cancer |
| Enrollment | 301 |
| Start date | Apr 7, 2003 |
| Primary completion | Jan 5, 2024 |
| Completion | Jan 5, 2024 |
| First posted | Sep 23, 2002 |
| Last update posted | Jan 8, 2024 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: